Chronic breathlessness is a neglected symptom of advanced diseases.
Aim:
To examine the effect of airflow for chronic breathlessness relief.
Design:
Exploratory systematic review and meta-analysis.
Data sources:
Medline, CINAHL, AMED and Cochrane databases were searched (1985–2018) for observational studies or randomised controlled trials of airflow as intervention or comparator. Selection against predefined inclusion criteria, quality appraisal and data extraction was conducted by two independent reviewers with access to a third for unresolved differences. ‘Before and after’ breathlessness measures from airflow arms were analysed. Meta-analysis was carried out where possible.
Results:
In all, 16 of 78 studies (n = 929) were included: 11 randomised controlled trials of oxygen versus medical air, 4 randomised controlled trials and 1 fan cohort study. Three meta-analyses were possible: (1) Fan at rest in three studies (n = 111) offered significant benefit for breathlessness intensity (0–100 mm visual analogue scale and 0–10 numerical rating scale), mean difference −11.17 (95% confidence intervals (CI) −16.60 to −5.74), p = 0.06 I2 64%. (2) Medical air via nasal cannulae at rest in two studies (n = 89) improved breathlessness intensity (visual analogue scale), mean difference −12.0 mm, 95% CI −7.4 to −16.6, p < 0.0001 I2 = 0%. (3) Medical airflow during a constant load exercise test before and after rehabilitation (n = 29) in two studies improved breathlessness intensity (modified Borg scale, 0–10), mean difference −2.9, 95% CI −3.2 to −2.7, p < 0.0001 I2 = 0%.
Conclusion:
Airflow appears to offer meaningful relief of chronic breathlessness and should be considered as an adjunct treatment in the management of breathlessness.
CurrowDCDal GrandeEFerreiraD, et al. Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Thorax2017; 72: 1151–1153.
2.
SmithAKCurrowDCAbernethyAP, et al. Prevalence and outcomes of breathlessness in older adults: a national population study. J Am Geriatr Soc2016; 64(10): 2035–2041.
3.
ParshallMB.Adult emergency visits for chronic cardiorespiratory disease: does dyspnea matter. Nurs Res1999; 48(2): 62–70.
4.
ParshallMBDohertyGS.Predictors of emergency department visit disposition for patients with chronic obstructive pulmonary disease. Heart Lung2006; 35(5): 342–350.
5.
HutchinsonAPickeringAWilliamsP, et al. Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med2017; 17(1): 53–57.
6.
BauseweinCBoothSGyselsM, et al. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med2010; 13(9): 1109–1118.
7.
BoothSSilvesterSToddC.Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care2003; 1(4): 337–344.
8.
WilliamsVBrutonAEllis-HillC, et al. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis2007; 4(2): 77–85.
9.
JohnsonMJYorkeJHansen-FlaschenJ, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J2017; 49(5): 1602277.
10.
FarquharMCPrevostATMcCroneP, et al. The clinical and cost effectiveness of a breathlessness intervention service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial. Trials2016; 17: 185–116.
11.
HigginsonIJBauseweinCReillyCC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med2014; 2(12): 979–987.
12.
BartonREnglishANabbS, et al. A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer2010; 70(3): 313–319.
13.
JohnsonMJBoothSCurrowDC, et al. A mixed-methods, randomized, controlled feasibility trial to inform the design of a phase III trial to test the effect of the handheld fan on physical activity and carer anxiety in patients with refractory breathlessness. J Pain Symptom Manage2016; 51(5): 807–815.
14.
BoothSGalbraithSRyanR, et al. The importance of the feasibility study: lessons from a study of the hand-held fan used to relieve dyspnea in people who are breathless at rest. Palliat Med2016; 30(5): 504–509.
15.
SwanFBoothS.The role of airflow for the relief of chronic refractory breathlessness. Curr Opin Support Palliat Care2015; 9(3): 206–211.
16.
BauseweinCBoothSGyselsM, et al. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care2010; 9: 22.
17.
GalbraithSFaganPPerkinsP, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage2010; 39(5): 831–838.
18.
SchwartzsteinRMLahiveKPopeA, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis1987; 136(1): 58–61.
19.
LissHPGrantBJ.The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis1988; 137(6): 1285–1288.
20.
ParshallMBSchwartzsteinRMAdamsL, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med2012; 185(4): 435–452.
21.
JohnsonMJSimpsonMIGCurrowDC, et al. Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot. BMJ Open2015; 5(6): e007535.
22.
Morelot-PanziniC.Fooling the brain to alleviate dyspnoea. Eur Respir J2017; 50(2): 1701383.
23.
LuckettTPhillipsJJohnsonMJ, et al. Contributions of a hand-held fan to self-management of chronic breathlessness. Eur Respir J2017; 50(2): 1700262.
24.
MularskiRReinkeLCarrieri-KohlmanV, et al. An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc2013; 10(5): S98–S106.
25.
Ben-AharonIGafter-GviliAPaulM, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol2008; 26(14): 2396–2404.
26.
BoothSWadeRJohnsonM, et al. The use of oxygen in the palliation of breathlessness. A report of the Expert Working Group of the Scientific Committee of the Association of Palliative Medicine. Respir Med2004; 98(1): 66–77.
27.
Cranston JosephineMCrockettACurrowD. Oxygen therapy for dyspnoea in adults. Cochrane Database Syst Rev2008; 3: CD004769.
28.
UronisHECurrowDCMcCroryDC, et al. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer2008; 98(2): 294–299.
29.
AbernethyAPMcDonaldCFFrithPA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet2010; 376(9743): 784–793.
30.
BellECCoxNSGohN, et al. Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev2017; 26(143): 160080.
31.
EkstromMAhmadiZBornefalk-HermanssonA, et al. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev2016; 11: CD006429.
32.
BoothSKellyMJCoxNP, et al. Does oxygen help dyspnea in patients with cancer. Am J Respir Crit Care Med1996; 153(5): 1515–1518.
33.
HigginsJPTGreenS. Cochrane handbook for systematic reviews of interventions (version 5.1.0) [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org
34.
MoherDLiberatiATetzlaffJ, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 6: e1000097.
35.
BauseweinCBoothSGyselsM, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev2008; 2: CD005623.
36.
Royal College of Physicians. Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. A report of the Royal College of Physicians. London: Royal College of Physicians, 1999.
37.
UronisHMcCrory SamsaGCurrowD, et al. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev2011; 6: CD006429.
38.
Long term domiciliary oxygen in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party. Lancet1981; 1: 681–686.
PowersJBennettS.Measurement of dyspnea in patients treated with mechanical ventilation. Am J Crit Care1999; 8(4): 254–261.
41.
HjermstadMJFayersPMHaugenDF, et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage2011; 41(6): 1073–1093.
42.
HozoSDjulbegovicBHozoI.Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol2005; 5: 13.
43.
DeeksJJHigginsJPTAltmanDG.Chapter 9: analysing data and undertaking meta-analyses. In: HigginsJPTGreenS (eds) Cochrane handbook for systematic reviews of interventions (Cochrane Book Series). London: The Cochrane Collaboration, 2011, pp. 243–296.
44.
WongSLLeongSMChanCM, et al. The effect of using an electric fan on dyspnea in Chinese patients with terminal cancer. Am J Hosp Palliat Care2017; 34(1): 42–46.
45.
EatonTFergussonWKolbeJ, et al. Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur Respir J2006; 27(4): 697–704.
46.
EvesNDSandmeyerLCWongEY, et al. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest2009; 135(3): 609–618.
47.
JollyECDi BoscioVAguirreL, et al. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest2001; 120(2): 437–443.
48.
MarciniukDDButcherSJReidJK, et al. The effects of helium-hyperoxia on 6-mm walking distance in COPD: a randomized, controlled trial. Chest2007; 131(6): 1659–1665.
49.
McDonaldCFBlythCMLazarusMD, et al. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med1995; 152(5Pt 1): 1616–1619.
50.
MooreRPBerlowitzDJDenehyL, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax2011(1): 32–37.
51.
PhilipJGoldMMilnerA, et al. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage2006; 32(6): 541–550.
52.
ScorsoneDBartoliniSSaporitiR, et al. Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD?Chest2010; 138(5): 1133–1139.
53.
WadellKHenriksson-LarsenKLundgrenR.Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J Rehabil Med2001; 33(5): 200–205.
54.
JohnsonMJBlandJMOxberrySG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage2013; 46(6): 957–963.
55.
RiesA.Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD2005; 2(1): 105–110.
56.
CurrowDCAbernethyAPJohnsonMJ.Activity as a measure of symptom control. J Pain Symptom Manage2012; 44(5): e1–e2.
57.
MaddocksMTaylorVKlezlovaR, et al. When will I get my breath back? Recovery time of exercise-induced breathlessness in patients with thoracic cancer. Lung Cancer2012; 76(1): 128–129.
58.
JohnsonMJSimpsonMMillmanR, et al. Magnetoencephalography as a neuro-imaging method in chronic dyspnoea: a feasibility study. Eur Respir J2014; 44(Suppl 58): P670.
59.
BaltzanMAAlterARotapleM, et al. Fan to palliative exercise-induced dyspnoea with severe COPD. Am J Respir Crit Care Med2000; 161(3 suppl): A59.
60.
MarchettiNTravalineJCrinerG.Air current applied to the face of COPD patients enhances leg ergometry performance. Am Rev Respir Dis2004; 169: A773.
61.
ResnickBSpellbringA.Understanding what motivates older adults to exercise. J Gerontol Nurs2000; 26(3): 34–42.
62.
KeatingALeeAHollandAE.What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis2011; 8(2): 89–99.
63.
FischerMJScharlooMAbbinkJJ, et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med2009; 103(10): 1564–1571.
64.
RiesALKaplanRMMyersR, et al. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med2003; 167(6): 880–888.
65.
HeppnerPSMorganCKaplanRM, et al. Regular walking and long-term maintenance of outcomes after pulmonary rehabilitation. J Cardiopulm Rehabil2006; 26(1): 44–53.
66.
MarchettiNLammiMRTravalineJM, et al. Air current applied to the face improves exercise performance in patients with COPD. Lung2015; 193(5): 725–731.
67.
FarquharMCPrevostATMcCroneP, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med2014; 12: 194.
68.
HigginsJPThompsonSG.Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21(11): 1539–1558.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
